Intuitive Surgical: revenue up 22% as procedures rise 15%, guidance narrowed
Intuitive Surgical posted 22% revenue growth and 15% procedure growth in Q3, narrowed its 2026 da Vinci guidance and flagged upcoming pricing changes.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Intuitive Surgical (ISRG) reported third-quarter revenue up 22%, while procedures climbed 15%. The gain was driven by broad system placements and growth across its da Vinci and Ion platforms.
For fiscal 2026 the company narrowed its da Vinci procedure growth forecast to 14% to 15%. It also expects planned pricing changes to lower I&A revenue per procedure by 3% to 5% at constant mix once fully implemented.
why it matters
Two points matter for investors: revenue is growing faster than procedure-level pricing would suggest, and lower revenue per case may limit the benefit of higher volumes. The narrower forecast gives clearer reference points, but the full effect of the pricing changes is not yet visible in reported figures.
market impact
ISRG: tighter guidance and planned per-procedure price cuts shape expectations for the company's revenue
tags
instruments
sources
- ISRG: Revenue grew 22% as procedures rose 15%; guidance tightens and pricing actions loom — TradingView, 20 October 2026 at 23:31 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗